Order results by:
| Issue | Title | |
| Vol 12, No 2 (2016) | ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. V. Rodionov | ||
| "... and safety of apixaban with these of warfarin in patients with atrial fibrillation and a history of ischemic ..." | ||
| Vol 8, No 6 (2012) | HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| S. V. Moiseev | ||
| "... and systemic embolic events in more than 18000 patients with nonvalvular atrial fibrillation. At that time ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..." | ||
| Vol 10, No 2 (2014) | CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... (IHD) and paroxysmal atrial fibrillation (AF) during treatment with amiodarone 200 mg daily compared ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..." | ||
| Vol 7, No 4 (2011) | SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS | Abstract similar documents |
| E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts | ||
| "... in 68 patients with atrial fibrillation due to ischemic heart disease. Adjusted warfarin dose ..." | ||
| Vol 9, No 1 (2013) | ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION | Abstract similar documents |
| A. N. Zakirova, E. R. Abdukova, N. E. Zakirova | ||
| "... fibrillation (AF) in patients with ischemic heart disease (IHD) complicated by chronic heart failure (CHF ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF ..." | ||
| Vol 21, No 2 (2025) | Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation | Abstract similar documents |
| E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurbanalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev | ||
| "... with cardioembolic (CE) subtype ischemic stroke (IS) and atrial fibrillation (AF) hospitalized in a specialized ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... The choice of anticoagulant therapy in patients with atrial fibrillation (AF) and concomitant ..." | ||
| Vol 12, No 5 (2016) | The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin | Abstract similar documents |
| I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich | ||
| "... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..." | ||
| Vol 19, No 1 (2023) | Atrial Fibrillation: a Marker or Risk Factor for Stroke | Abstract similar documents |
| B. A. Tatarsky, D. A. Napalkov | ||
| "... Atrial fibrillation (AF) is strongly associated with stroke risk, but an association by itself ..." | ||
| Vol 6, No 4 (2010) | ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS | Abstract similar documents |
| A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov | ||
| "... associated with nonvalvular atrial fibrillation, particularly ischemic stroke. Confirmation of the efficacy ..." | ||
| Vol 19, No 5 (2023) | Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) | Abstract similar documents |
| V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina | ||
| "... cardiovascular events) in outpatients with atrial fibrillation (AF) in one of the Yaroslavl clinics for 10 years ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... Aim. To study the changes that have occurred in the pharmacotherapy of atrial fibrillation (AF ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring ..." | ||
| Vol 9, No 3 (2013) | ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS | Abstract similar documents |
| S. S. Davydova | ||
| Vol 10, No 2 (2014) | SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT | Abstract similar documents |
| E. A. Drozdova | ||
| "... Atrial fibrillation is one of the main risk factor of ischemic stroke. Current problems ..." | ||
| Vol 19, No 2 (2023) | Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment | Abstract similar documents |
| O. R. Eshmatov, M. S. Khlynin, R. E. Batalov, E. A. Archakov, I. V. Kisteneva | ||
| "... Aim. To study the efficacy and safety of antithrombotic therapy in patients with paroxysmal atrial ..." | ||
| Vol 14, No 4 (2018) | Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice | Abstract similar documents |
| N. M. Vorobyeva, O. N. kacheva | ||
| "... The possibility of rivaroxaban using in elderly patients with non-valvular atrial fibrillation ..." | ||
| Vol 12, No 4 (2016) | Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation | Abstract similar documents |
| S. G. Kanorskii | ||
| "... in routine clinical practice in patients with non-valvular atrial fibrillation. In consecutive patients who ..." | ||
| Vol 12, No 6 (2016) | THE PREVALENCE OF ELECTROCARDIOGRAPHIC INDICATORS AMONG MEN AND WOMEN OF OLDER AGES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| G. A. Muromtseva, A. D. Deev, V. V. Konstantinov, A. A. Shalnova, S. A. Boytsov | ||
| "... ischemia, atrial fibrillation, conduction abnormalities). Almost two-fold increase in the incidence ..." | ||
| Vol 13, No 2 (2017) | ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC | Abstract PDF (Eng) similar documents |
| E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov | ||
| "... fibrillation (AF) associated with hypertension (HT), ischemic heart disease (IHD) and chronic heart failure ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... (p<0.001). Women more often than men suffered from hypertension (p=0.01) and atrial fibrillation (p=0 ..." | ||
| Vol 17, No 1 (2021) | Myocardial Infarction Complicated by Ischemic Stroke: Risk Factors, Prognosis, Unresolved Problems and Possible Methods of Prevention | Abstract similar documents |
| M. V. Zykov, V. V. Butsev, R. R. Suleymanov | ||
| "... in a timely manner, to register preexisting atrial fibrillation that occurs earlier or for the first time ..." | ||
| Vol 17, No 2 (2021) | Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care | Abstract PDF (Eng) similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova | ||
| "... .8%), atrial fibrillation (37.0 and 41.5%), chronic heart failure (90.4% vs 91.2%), diabetes (26.7% vs 24 ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... was estimated by atrial fibrillation frequency in postoperative period and time before hospital discharge after ..." | ||
| Vol 14, No 6 (2018) | Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... with atrial fibrillation after 2 years of observation. ..." | ||
| Vol 16, No 4 (2020) | The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... . The authors analyzed a large database of patients with atrial fibrillation and concluded that rivaroxaban ..." | ||
| Vol 16, No 4 (2020) | Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation | Abstract similar documents |
| L. I. Folomeeva, E. V. Filippov | ||
| "... Supraventricular arrhythmias, including atrial fibrillation (AF), are a current problem ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... Atrial fibrillation (AF) – is the most common tachyarrhythmia, which is diagnosed in 1-2 ..." | ||
| Vol 15, No 6 (2019) | Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation | Abstract similar documents |
| M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin | ||
| "... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..." | ||
| Vol 11, No 4 (2015) | CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, I. Z. Loriya | ||
| "... atrial fibrillation (AF) treated with various antiarrhythmic drugs. Material and methods. Patients ..." | ||
| Vol 9, No 6 (2013) | DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi | ||
| "... (IHD) and persistent atrial fibrillation (AF) compared among those treated with amiodarone 200 mg daily ..." | ||
| Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
| "... for cardiovascular complications. Atrial fibrillation is associated with a higher risk of developing chronic kidney ..." | ||
| Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
| E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
| "... to 2018. Formal appropriateness of oral anticoagulants (OАС) prescriptions for 6,638 patients with atrial ..." | ||
| Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... cardioversion (DCC) in patients with persistent atrial fibrillation (AF). Material and methods. 60 patients ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... Background. For prevention of thromboembolic events in patients with non-valvular atrial ..." | ||
| Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
| D. A. Napalkov, E. N. Golovenko | ||
| "... . Ramipril efficacy in ischemic heart disease prevention as well as ramipril positive effect on myocardium ..." | ||
| Vol 15, No 2 (2019) | Current Predictors of Atrial Fibrillation Progression | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... Aim. To identify predictors of progression of atrial fibrillation (AF) in patients ..." | ||
| Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
| N. A. Novikova, A. N. Volovchenko | ||
| "... Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic ..." | ||
| Vol 18, No 2 (2022) | The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients | Abstract similar documents |
| O. A. Rubanenko, A. O. Rubanenko | ||
| "... Aim. To study the factors associated with the development of postoperative atrial fibrillation ..." | ||
| Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
| A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
| "... in patients older than 75 years with atrial fibrillation. Material and methods. Patients (n=431) over 75 ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... Aim. To identify predictors of paroxysmal atrial fibrillation (pAF) in patients with stable angina ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... anticoagulants in comparison with warfarin in a population of patients with atrial fibrillation and chronic ..." | ||
| Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
| "... Prevalence of atrial fibrillation (AF) in population is very high and continues to grow. According ..." | ||
| Vol 9, No 3 (2013) | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik | ||
| "... , atrial fibrillation, and diabetes mellitus. Various aspects of the treatment of patients with vascular ..." | ||
| Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
| "... Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF ..." | ||
| Vol 13, No 5 (2017) | LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE | Abstract similar documents |
| E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin | ||
| "... remodeling and are related to the atrial fibrillation progression from paroxysmal to permanent forms ..." | ||
| Vol 16, No 2 (2020) | The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov | ||
| "... on the risk of myocardial infarction in patients with atrial fibrillation. A pivotal RE-LY study on dabigatran ..." | ||
| Vol 11, No 1 (2015) | CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina | ||
| "... of hypertension was present in 833 patients (86.8%), atrial fibrillation in 252 (26.8%) patients, 199 (20 ..." | ||
| Vol 10, No 4 (2014) | DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... -cardiac diseases in patients with atrial fibrillation (AF) on the base of the data of registry ..." | ||
| Vol 20, No 2 (2024) | Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure | Abstract similar documents |
| A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova, E. V. Privalova, Yu. N. Belenkov | ||
| "... infarction, revascularization, stroke, death), new cases of atrial fibrillation, diabetes mellitus, decreased ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... Aim. To determine the proportion of patients with atrial fibrillation (AF) among hospitalized ..." | ||
| Vol 17, No 5 (2021) | Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias | Abstract similar documents |
| O. V. Blagova, A. V. Nedostup, E. A. Kogan | ||
| "... (mean age 43.1±11.3 years, 10 female) with atrial fibrillation (AF), supraventricular and ventricular ..." | ||
| Vol 7, No 6 (2011) | MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya | ||
| "... .05) and atrial fibrillation (AIR 0.94; 95%CI 0.52-1.56; р>0.05) was not significantly different in patients ..." | ||
| Vol 9, No 2 (2013) | LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. Yu. Martsevich, M. L. Ginzburg, N. P. Kutishenko, L. Yu. Drozdova, A. V. Akimova, A. Yu. Suvorov, M. M. Loukianov, N. A. Dmitrieva, O. V. Lerman, N. Yu. Zhuravskaya, E. V. Daniels, A. V. Fokina, V. N. Yudaev, V. P. Smirnov, A. M. Kalinina, S. V. Kotov, L. V. Stahovskaya | ||
| "... .0%) patients had history of arterial hypertension and 155 (24.3%) – of atrial fibrillation.147 (23.1%) patients ..." | ||
| Vol 7, No 2 (2011) | SUDDEN CARDIAC DEATH: ETIOLOGICY IN PATIENTS OF DIFFERENT AGES, RISK FACTORS AND PREVENTION | Abstract similar documents |
| O. V. Gaisenok | ||
| Vol 19, No 1 (2023) | Relief of persistent atypical atrial flutter: experience with the use of niferidil | Abstract similar documents |
| E. A. Zakharyan, D. V. Shatov, A. O. Povoroznyj, T. B. Bujar | ||
| "... in the population. Fibrillation and atrial flutter are among the most common causes of a decrease ..." | ||
| Vol 17, No 5 (2021) | Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... Aim. To estimate the role of omega-3 polyunsaturated fatty acids (PUFAs) administration in atrial ..." | ||
| Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
| "... Atrial fibrillation (AF) is the most common heart rhythm disturbance. It is believed ..." | ||
| Vol 13, No 3 (2017) | HYPERTHYROIDISM AND ATRIAL FIBRILLATION | Abstract similar documents |
| I. M. Marusenko, E. G. Petrova | ||
| "... Review on a problem of the development of atrial fibrillation in patients with thyrotoxicosis ..." | ||
| Vol 16, No 5 (2020) | Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation | Abstract similar documents |
| E. P. Popova, S. S. Puzin, O. T. Bogova, S. N. Puzin, D. A. Sychev, V. P. Fisenko | ||
| "... of atrial fibrillation (AF). Material and methods. Spectral analysis of heart rate variability of 5-minute ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... Comprehensive protection of a patient with atrial fibrillation (AF) should not only reduce ..." | ||
| Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
| A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
| "... in accordance with clinical guidelines. Material and methods. Control Of Anticoagulation Therapy in Atrial ..." | ||
| Vol 6, No 1 (2010) | ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| "... The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors ..." | ||
| Vol 10, No 3 (2014) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
| L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
| "... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..." | ||
| Vol 11, No 6 (2015) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
| L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
| "... of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use ..." | ||
| Vol 8, No 4 (2012) | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION | Abstract similar documents |
| E. A. Protasova, N. V. Furman, O. V. Reshet'ko | ||
| "... polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent ..." | ||
| Vol 17, No 1 (2021) | Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. A. Brazhnik, L. O. Minushkina, A. D. Erlikh, E. D. Kosmacheva, M. A. Chichkova, N. R. Khasanov, D. A. Zateyshchikov | ||
| "... in patients with acute coronary syndrome (ACS) undergoing anticoagulants for atrial fibrillation using ..." | ||
| Vol 17, No 5 (2021) | Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety | Abstract similar documents |
| N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin | ||
| "... for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data ..." | ||
| Vol 9, No 4 (2013) | ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION | Abstract similar documents |
| O. M. Drapkina, A. V. Emelyanov | ||
| "... in patients with atrial fibrillation are presented. New approaches to the treatment of atrial fibrillation ..." | ||
| Vol 15, No 5 (2019) | Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies | Abstract similar documents |
| Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... the prognosis of patients (pts) with stable ischemic heart disease (IHD) was confirmed in a randomized ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... with atrial fibrillation (AF) and chronic kidney disease (CKD) with modern clinical guidelines. Material ..." | ||
| Vol 13, No 1 (2017) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) | Abstract PDF (Eng) similar documents |
| S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev | ||
| "... %, and anticoagulants in atrial fibrillation – 17.6% vs 2.3%, respectively). Mortality rates in the ACVA-AR and ACVA-FV ..." | ||
| Vol 14, No 6 (2018) | Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov | ||
| "... for coronary heart disease (CHD) – 47.2% vs 27.9%; antiplatelet agents for CHD without atrial fibrillation – 65 ..." | ||
| Vol 17, No 6 (2021) | Drug-Induced Atrial Fibrillation / Atrial Flutter | Abstract similar documents |
| O. D Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, A. E. Vorobieva, D. I. Bakhteeva, S. P. Korchagina, O. V. Bondarets, N. D. Boyko, D. A. Sychev | ||
| "... Drug-induced atrial fibrillation / flutter (DIAF) is a serious and potentially life-threatening ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 8, No 1 (2012) | RANOLAZINE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. P. Lupanov | ||
| "... ) are presented. Indications, contraindications, major clinical trials of the drug in patients with ischemic heart ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... patients with paroxysmal atrial fibrillation (AF) in the longterm follow-up. Material and methods ..." | ||
| Vol 12, No 5 (2016) | Pathogenic Mechanisms of Atrial Fibrillation in Obesity | Abstract similar documents |
| O. M. Drapkina, M. V. Nikolaeva | ||
| "... Atrial fibrillation (AF) is one of the most common arrhythmias. It reduces quality of life and its ..." | ||
| Vol 7, No 3 (2011) | PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| V. A. Sulimov, A. S. Lishuta | ||
| "... Basic principles of the management of patients with atrial fibrillation (AF) are discussed taking ..." | ||
| Vol 4, No 2 (2008) | CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION | Abstract similar documents |
| S. Y. Nikulina, V. A. Schulman, O. O. Kuznetsova, N. V. Aksjutina, P. A. Shesternja, A. A. Chernova, V. N. Maksimov, I. V. Kulikov, S. N. Ustinov, Y. L. Kazarinova, A. G. Romashchenko, M. I. Voevoda | ||
| "... Aim. To study inheritance patterns of atrial fibrillation (AF) and association of primary ..." | ||
| Vol 12, No 6 (2016) | ANNUAL FORECAST IN PATIENTS WITH ACUTE ISCHEMIC STROKE: ROLE OF PATHOLOGICAL ANKLE-BRACHIAL INDEX | Abstract similar documents |
| A. N. Sumin, J. A. Kolmykova, I. N. Kukhareva, M. V. Ott, N. I. Vodopyanova, A. A. Morkvenas, O. A. Trubnikova, A. V. Kovalenko | ||
| "... heart failure, atrial fibrillation, previous cardiovascular events, presence of peripheral ..." | ||
| Vol 12, No 2 (2016) | ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION | Abstract similar documents |
| Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev | ||
| "... Modern approaches to antiarrhythmic anti-relapse therapy of atrial fibrillation are considered ..." | ||
| Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| "... and usage prospects of dabigatran in patients with atrial fibrillation are discussed in detail in the light ..." | ||
| Vol 7, No 2 (2011) | PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE | Abstract similar documents |
| I. V. Graifer, O. V. Reshet'ko, N. V. Furman | ||
| "... Aim. To analyze current clinical practice in the treatment of atrial fibrillation (AF ..." | ||
| Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
| "... and international normalized ratio (INR) control for patients with atrial fibrillation (AF) per 1 year of treatment ..." | ||
| Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
| "... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..." | ||
| Vol 16, No 4 (2020) | Telocytes and Atrial Fibrillation: From Basic Research to Clinical Practice | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. S. Frolova | ||
| "... , and molecular causes of atrial fibrillation (AF). Recently, the role of interstitial telocyte cells ..." | ||
| Vol 8, No 3 (2012) | RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| M. Yu. Gilyarov | ||
| "... The possibilities of antithrombotic therapy in atrial fibrillation are highlighted ..." | ||
| Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
| M. Yu. Gilyarov | ||
| "... Up to date antithrombotic medications applied in patients with atrial fibrillation are discussed ..." | ||
| Vol 8, No 5 (2012) | POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov | ||
| "... Aim. To identify possible predictors of atrial fibrillation (AF) recurrence in 6-month ..." | ||
| Vol 14, No 3 (2018) | CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension ..." | ||
| Vol 17, No 1 (2021) | Asymptomatic Supraventricular Arrhythmias in Patients Undergoing Dialysis | Abstract similar documents |
| O. V. Likhachev-Mishchenko, A. A. Kornienko, N. A. Kornienko, L. A. Khaisheva, A. A. Dyuzhikov, S. V. Shlyk | ||
| "... a higher risk of nonfatal cardiovascular events (HR 4.32; 95%CI 2.11-8.83) and symptomatic atrial ..." | ||
| Vol 15, No 5 (2019) | Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... and their combinations on the survival of patients with atrial fibrillation (AF) in the REKUR-AF study. Material ..." | ||
| Vol 17, No 6 (2021) | Atrial Fibrillation in Cancer Patients: Who is at Risk? | Abstract similar documents |
| Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger | ||
| "... to reduce the effectiveness of cancer patient’s treatment. Atrial fibrillation is frequent ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... Aim. To evaluate outcomes and risk of their occurrence in patients with atrial fibrillation (AF ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| "... embolism prevention in patients with atrial fibrillation (AF). Aim. Based on the RE-LY study to evaluate ..." | ||
| 1 - 100 of 719 Items | 1 2 3 4 5 6 7 8 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
